期刊文献+

碳青霉烯类抗生素与阿奇霉素联用对鲍曼不动杆菌生物被膜的效应研究 被引量:3

Effects of carbapenems combined with azithromycin on the biofilm of Acinetobacter baumannii
下载PDF
导出
摘要 目的探讨碳青霉烯类药物单用或联合常用的抗被膜药物阿奇霉素对鲍曼不动杆菌生物被膜的作用。方法微量肉汤法检测亚胺培南、美罗培南对鲍曼不动杆菌浮游菌、被膜菌的敏感性,观察不同浓度的药物单药或联合阿奇霉素(AZI)时对鲍曼不动杆菌被膜的影响,用结晶紫实验观察被膜量的变化,用被膜下细菌计数的方法检测被膜细菌活力的改变。结果 4×MIC浓度的亚胺培南、美罗培南可以降低部分鲍曼不动杆菌的被膜量,剩余被膜量在17%~70%之间,被膜下细菌活力也有降低。与AZI联用时,鲍曼不动杆菌剩余被膜量较单用亚胺培南、美罗培南相比反而有所升高。结论碳青霉烯类药物可以有效降低细菌的被膜量及被膜下细菌,与阿奇霉素联用并不能增强其对被膜的活性。 Objective To investigate the effect ofcarbapenem alone or in combination with the commonly used anti-biofilm drug azithromycin on the biofilm ofAcinetobacter baumannii. Methods The susceptibility of imipenem and meropenem to Acinetobacter baumannii planktonic and biofilm bacteria were observed by the broth microdilution method. The effects of imipenem (IMP), meropenem (MERO) monotherapy or the combination with azithromycin (AZI) on the biofilm of Acinetobacter baumannii were confirmed by the use of the crystal violet experiment to observe the changes in the amount of biofilm, and counting the bacteria under the biofilm to detect bacterial changes. Results IMP and MERO of 4~MIC could decrease the biomass of Acinetobacter baumannii biofilms, and the amount of residual biofilm was between 17% and 70%. The number of bacteria under the biofilm was also decreased. When combined with AZI, the amount of residual biofilm biomass was increased compared to carbapenem alone. Conclusion Carbapenems can effectively reduce the biomass ofAcinetobacter baumannii biofilms and the bacterial viability under the biofilm. Moreover, azithromycin in combination with carbapenem can not enhance the activity of imipenem and meropenem against biofilms ofAcinetobacter baumannii.
出处 《中国抗生素杂志》 CAS CSCD 北大核心 2017年第12期1040-1045,共6页 Chinese Journal of Antibiotics
基金 国家自然科学基金(No.81570008) 广东省自然科学基金(No.2014A030313052) 中山大学科技成果转化类项目(No.2017-9)
关键词 鲍曼不动杆菌 生物被膜 碳青霉烯类抗生素 阿奇霉素 Acinetobacter baumannii Biofilm Carbapenem Azithromycin
  • 相关文献

参考文献2

二级参考文献21

  • 1王辉,郭萍,孙宏莉,杨启文,陈民钧,朱元珏,徐英春,谢秀丽.碳青霉烯类耐药的不动杆菌分子流行病学及其泛耐药的分子机制[J].中华检验医学杂志,2006,29(12):1066-1073. 被引量:237
  • 2方向群,刘又宁.亚胺培南联合阿奇霉素治疗铜绿假单胞菌生物被膜感染的实验研究[J].中华医院感染学杂志,2007,17(3):254-257. 被引量:34
  • 3Chastre J, Fagon JY. Ventilator-associated pneumonia. Am J Respir Crit Care Med, 2002,165 : 867-903. 被引量:1
  • 4Fagon JY, Chastre J, Hance A J, et al. Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay. Am J Med, 1993,94:281-288. 被引量:1
  • 5Rello J, Ollendorf DA, Oster G, et al. Epidemiology and outcomes of pneumonia in a large US database. Chest, 2002,122 : 2115-2121. 被引量:1
  • 6Safdar N, Dezfulian C, Collard HR, et al. Clinical and economic consequences of ventilator-associated pneumonia: a systematic review. Crit Care Med, 2005, 33 : 2184-2193. 被引量:1
  • 7Luna CM, Vujacich P, Niederman MS, et al. Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia. Chest, 1997, 111: 676-685. 被引量:1
  • 8Horan TC, Gaynes RP. Surveillance of nosocomial infections. In : Hospital Epidemiology and Infection Control, 3rd ed. Mayhall CG, editor. Philadelphia: Lippincott Williams & Wilkins, 2004: 1659-1702. 被引量:1
  • 9Clinical and Laboratory Standards Institute. Performance standards for antimicrohial susceptibility testing; twentieth informational supplement. Vol. 30. Wayne : Pennsylvania( USA. ), 2010 : M100- S19. 被引量:1
  • 10Pach6n-Ib6fiez ME, Jim6nez-Mejias ME, Pichardo C, et al. Activity of tigecycline ( GAR-936 ) against Acinetobacter baumannii strains, including those resistant to imipenem. Antimicrob Agents Chemother, 2004,48:4479-4481. 被引量:1

共引文献150

同被引文献42

引证文献3

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部